Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02469532 · ClinicalTrials.gov registry record
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
A clinical trial, sponsored by Mercator MedSystems.
- Completed
- Registry status
- 31
- Enrollment target
NCT02469532: Completed study, sponsored by Mercator MedSystems.
NCT02469532 is a clinical trial that has completed, run by Mercator MedSystems. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02469532 has completed, sponsored by Mercator MedSystems.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, observational registry to document the baseline, 24-hour and 30-day inflammatory response and procedural outcomes out to 12 month follow-up after femoropopliteal angioplasty or atherectomy-based revascularization procedures.
Interventions
- DEVICE Balloon Angioplasty
- DEVICE Atherectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02469532
The ClinicalTrials.gov registry entry for NCT02469532 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercator MedSystems, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Balloon Angioplasty is the first listed.
NCT02469532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02469532 about?
NCT02469532 is a clinical study titled "DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes". This is a prospective, multi-center, observational registry to document the baseline, 24-hour and 30-day inflammatory response and procedural outcomes out to 12 month follow-up after femoropopliteal angioplasty or atherectomy-based revascularization procedures.
What is the current status of trial NCT02469532?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2015-05. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02469532?
The interventions under investigation include: Balloon Angioplasty (DEVICE), Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT02469532?
This trial is sponsored by Mercator MedSystems, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.